³ª½Â¿î

  • Áø·á°ú

    ½ÉÇ÷°ü¼¾ÅÍ(¼øȯ±â)

  • Àü¹®Áø·áºÐ¾ß

    Çù½ÉÁõ, ½É±Ù°æ»ö, ½ÉÇ÷°üÁßÀç½Ã¼ú, ¸»ÃÊÇ÷°üŬ¸®´Ð (¿¬±¸³â(2023.03~2023.08))

  • ´ã´çŬ¸®´Ð

    °ü»óµ¿¸ÆÁúȯ

  • °ü·Ã¼¾ÅÍ

    ½ÉÇ÷°ü¼¾ÅÍ

³ª½Â¿î
¼¼ºÎÀü°ø
ÇãÇ÷¼º ½ÉÁúȯ, ¸»ÃÊÇ÷°üÁúȯ, °íÇ÷¾Ð, °íÁöÇ÷Áõ
Áúȯ±º
Çù½ÉÁõ, ½É±Ù°æ»öÁõ, ¸»ÃÊÇ÷°üÁúȯ, °íÇ÷¾Ð, ÀÌ»óÁöÇ÷Áõ
Áõ»ó±º
°¡½¿ÅëÁõ, ´Ù¸®ÅëÁõ, ´ç´¢¹ß, °æµ¿¸Æ ÇùÂø, ´ëµ¿¸ÆÁúȯ, Á¤¸ÆÇ÷ÀüÁõ, ºÎÁ¾, °íÇ÷¾Ð, °íÁöÇ÷Áõ

³ª½Â¿î ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
½ÉÇ÷°ü¼¾ÅÍ(¼øȯ±â) - - - - - - Çù½ÉÁõ, ½É±Ù°æ»ö, ½ÉÇ÷°üÁßÀç½Ã¼ú, ¸»ÃÊÇ÷°üŬ¸®´Ð (¿¬±¸³â(2023.03~2023.08))

³ª½Â¿î ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1985 .03  ~  1993 .02  :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú ÀÇÇлç
  • 1995 .03  ~  1997 .02  :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ´ëÇпø ³»°ú ¼øȯ±â ³»°úÇÐ ¼®»ç
  • 1997 .09  ~  2003 .02  :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ´ëÇпø ³»°ú ¼øȯ±â ³»°úÇÐ ¹Ú»ç

°æ·Â

more
  • 1993 .03  ~  1994 .02  :  °í·Á´ëÇб³ ÀÇ·á¿ø ÀÎÅÏ
  • 1994 .03  ~  1998 .02  :  °í·Á´ëÇб³ ÀÇ·á¿ø ³»°ú Àü°øÀÇ
  • 1998 .03  ~  1999 .02  :  ½Å¶óº´¿ø (¼ººÏ±¸ ¼ÒÀç Á¾ÇÕº´¿ø) ³»°ú°úÀå
  • 1999 .03  ~  2002 .04  :  ±¹¸³ ³ªÁÖº´¿ø : ³»°ú°úÀå
  • 2002 .05  ~  2003 .02  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¼øȯ±â³»°ú ÀüÀÓÀÇ
  • 2003 .03  ~  2003 .03  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼øȯ±â³»°ú ÀüÀÓÀÇ
  • 2003 .04  ~  2004 .06  :  Washington Hospital Center, Georgetown University, Washington DC, USA ¿¬±¸±³¼ö
  • 2004 .07  ~  2005 .02  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼øȯ±â³»°ú ÀÓ»óÁ¶±³¼ö
  • 2005 .03  ~  2008 .02  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼øȯ±â³»°ú Á¶±³¼ö
  • 2008 .03  ~  2013 .02  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼øȯ±â³»°ú ºÎ±³¼ö
  • 2013 .03  ~   :  ÇöÀç °í·Á´ëÇб³ ±¸·Îº´¿ø ¼øȯ±â³»°ú ±³¼ö
  •  ~   :  °í´ë±¸·Îº´¿ø ¼øȯ±â³»°ú ºÐ°úÀå (Àü)
  •  ~   :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼øȯ±â³»°ú ±³¼ö (Çö)
  •  ~   :  °í´ë±¸·Îº´¿ø ½ÉÇ÷°ü¼¾ÅÍ ¼ÒÀå (Çö)
  •  ~   :  °í´ë±¸·Îº´¿ø ½ÉµµÀÚ½ÇÀå (Çö)
  •  ~   :  °í´ë±¸·Îº´¿ø ¼øȯ±â³»°ú ÁßÀç½Ã¼ú¿¬±¸¼Ò (CIRI) ¼ÒÀå (Çö)
  •  ~   :  °í·Á´ëÇб³ ½ÉÀåÇ÷°ü¿¬±¸¼Ò (CRI) ¼ÒÀå (Çö)
  •  ~   :  °í·Á´ëÇб³ ÀÇ·á¿ø ¼øȯ±â³»°ú ÁÖÀÓ±³¼ö (Çö)
  •  ~   :  °í·Á´ëÇб³ ÀÇ·á¿ø ³»°úÇÐ ±³½Ç ºÎÁÖÀÓ±³¼ö (Çö)

¼ö»ó³»¿ª

more
  • 1994 .02 .28  :  °í·Á´ëÇб³ ÀÇ·á¿ø ÃÖ°í ÀÎÅÏ»ó
  • 1995 .02 .28  :  °í·Á´ëÇб³ ³»°úÇÐ ±³½Ç ÃÖ°í Àü°øÀÇ »ó
  • 2001 .12 .20  :  °øÁߺ¸°ÇÀÇ»ç º¸°Çº¹ÁöºÎ Àå°ü»ó, º¸°Çº¹ÁöºÎ
  • 2005 .03 .08  :  ¹Ì±¹½ÉÀåÇÐȸ ACC 2005 Newsworthy Abstract ¼±Á¤
  • 2005 .10 .18  :  ¹Ì±¹ ±¹Á¦ ½ÉÇ÷°ü ½Ã¼úÇÐȸ TCT 2005 Challenging Case Award ¼±Á¤ ÀÌ¿Ü ¼ö½ÊÆíÀÇ ÃÊ·Ï°ú Áõ·Ê¹ßÇ¥°¡ ¼ö»ó¿¡ ¼±Á¤µÇ¾úÀ½
  • 2013 .11  :  °í·Á´ëÇб³ ±³¿ø Çмú»ó, °í·Á´ëÇб³ ÃÑÀå
  • 2020 .01 .21  :  °íÀÇÀÇÇлó, °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ µ¿¹®È¸
  • 2021 .05 .05  :  ¼®Å¾¿¬±¸»ó, °í·Á´ëÇб³ ÃÑÀå

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇÑ ½ÉÀåÇÐȸ ±³À° ¼ö·ÃÀÌ»ç (Àü), Áø·áÁöħÀÌ»ç (Çö)
  •  ~   :  Çѱ¹ Ç÷°üÁúȯ ÁßÀç½Ã¼úÇÐȸ ȸÀå (Çö)
  •  ~   :  Çѱ¹ ½ÉÇ÷°ü ÇÕº´Áõ ¿¬±¸È¸ ȸÀå (Àü), °í¹® (Çö)
  •  ~   :  ´ëÇÑ ÀÓ»ó³ëÀÎÇÐȸ ±³À°ÀÌ»ç (Àü), ±âȹÀÌ»ç (Çö)
  •  ~   :  ´ëÇÑ ½ÉÇ÷°üÁßÀçÇÐȸ °£ÇàÀÌ»ç (Àü), ÆòÀÇ¿ø (Çö)
  •  ~   :  Çѱ¹ ½É±Ù°æ»öÁõ ¿¬±¸È¸ ¿¬±¸À§¿ø
  •  ~   :  Çѱ¹ °üµ¿¸Æ ¿ÏÀü¸¸¼ºÆó»ö ¿¬±¸È¸ ¿î¿µÀ§¿ø
  •  ~   :  Çѱ¹ ¿ä°ñµ¿¸Æ ÁßÀç½Ã¼ú¿¬±¸È¸ ¿î¿µÀ§¿ø

±¹¿ÜÈ°µ¿

more
  •  ~   :  ¾Æ½Ã¾ÆÅÂÆò¾ç ÁßÀç½Ã¼ú¿¬±¸È¸ Á¤È¸¿ø
  •  ~   :  À¯·´½ÉÀåÇÐȸ Á¤È¸¿ø
  •  ~   :  ¹Ì±¹ÁßÀç½Ã¼úÇÐȸ Á¤È¸¿ø
  •  ~   :  ¹Ì±¹½ÉÀåÇÐȸ Á¤È¸¿ø
  •  ~   :  ¹Ì±¹ÁßÀç½Ã¼úÇÐȸ Á¤È¸¿ø

³í¹®

more
  • [SCI] (ADAM10 inhibits the interaction between IL-17 and HMGB1 in Buerger's disease.)
  • [SCI] (Percutaneous Coronary Intervention for Chronic Total Occlusion in Single Coronary Arteries.)
  • [SCI] (Stenting versus balloon angioplasty alone in patients with below-the-knee disease: A propensity score-matched analysis.)
  • [SCI] (Long-term outcomes of peripheral arterial disease patients with significant coronary artery disease undergoing percutaneous coronary intervention.)
  • [SCI] (Other KAMIR-NIH investigators.Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).)
  • [SCI] (A relationship between unrecognized anaemia and the development of type 2 diabetes mellitus in patient with cardiovascular risks.)
  • [SCI] (Initial diastolic dysfunction is a powerful predictor of 5-year mortality in peripheral arterial disease patients undergoing percutaneous transluminal angioplasty.)
  • [SCI] (Diabetes mellitus is not a risk factor for coronary artery spasm as assessed by an intracoronary acetylcholine provocation test:Angiographic and clinical characteristics of 986 patients)
  • [SCI] (Duration of dual antiplatelet treatment in the era of next generation drug-eluting stents)
  • [±¹³»³í¹®] (The Impact of High Sensitivity C-Reactive Protein Level on Coronary Artery Spasm as Assessed by Intracoronary Acetylcholine Provocation Test)
  • [SCI] (Angiographic and Clinical Characteristics according to Intracoronary Acetylcholine Dose in Patients with Myocardial Bridge)
  • [SCI] (Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients)
  • [SCI] (Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction)
  • [SCI] (for the Korea Acute Myocardial Infarction Registry Investigators. 'Smoker's paradox' in young patients with acute myocardial infarction)
  • [±¹³»³í¹®] (Impact of heterogeneous overlapping drug-eluting stents on the arterial responses of rabbit iliac arteries: a comparison with overlapping bare metal stents)
  • [SCI] (other Korea Acute Myocardial Infarction Registry Investigators. Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents)
  • [SCI] (LAMIS Investigators. Long-Term Safety and Efficacy of Pitavastatin in Patients With Acute Myocardial Infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS]))
  • [±¹¿Ü³í¹®] (The usefulness of three-dimensional multidetector computed tomography to delineate pericardial calcification in constrictive pericarditis)
  • [±¹¿Ü³í¹®] (Neutropenia associated with clopidogrel use in a patient with chronic renal failure who underwent percutaneous coronary and peripheral intervention)
  • [±¹¿Ü³í¹®] (Acute myocardial infarction in a 14-year old boy by thrombotic occlusion of the left main coronary ostium)
  • [±¹¿Ü³í¹®] (Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention)
  • [±¹¿Ü³í¹®] (Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents)
  • [±¹¿Ü³í¹®] (Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention)
  • [±¹¿Ü³í¹®] (A case of coronary arteriovenous malformation in variant angina pectoris)
  • [±¹¿Ü³í¹®] (The influence of coronary dominance on coronary atherosclerosis and distribution of coronary artery disease in Korean)
  • [±¹¿Ü³í¹®] (Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents)
  • [±¹¿Ü³í¹®] (Decrease in plasma adiponectin concentrations in patients with variant angina pectoris)

Àú¼­

more
  • TRI (Transradial intervention) manual
  • °üµ¿¸Æ ¸¸¼º¿ÏÀüÆó»ö º´º¯ÀÇ ½Ã¼ú ¸Å´º¾ó
  • VIS (Vascular Intervention Seminar) manual
  • Coronary Stent Restenosis
  • ½ÉÀåÀÌ Æò»ý °Ç°­À» Á¿ìÇÑ´Ù
  • ½ÉÇ÷°üÁßÀç¸Å´º¾ó

ÃÖÁ¾¼öÁ¤ÀÏ : 2021.08.02